Home › Crohn's Disease › Washington › Tacoma
Pag-aaral pangklinika para sa Crohn's Disease sa Tacoma, WA
Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tacoma. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma ( Site 5004), Tacoma
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Nagre-recruitPhase 2
- Washington Gastroenterology - Tacoma /ID# 267302, Tacoma
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2/3
- GI Alliance Tacoma, Tacoma
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Nagre-recruitPhase 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
- GI Alliance Tacoma, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Nagre-recruitPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Nagre-recruitPhase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Tacoma
Pag-aaral para sa Crohn's Disease sa ibang lungsod
- New York City, NY35 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL19 pag-aaral
- Cleveland, OH19 pag-aaral
- St. Louis, MO19 pag-aaral
- Tyler, TX17 pag-aaral
- Houston, TX17 pag-aaral
- Orlando, FL17 pag-aaral
- Atlanta, GA17 pag-aaral
- San Antonio, TX15 pag-aaral
- Los Angeles, CA15 pag-aaral
- San Diego, CA15 pag-aaral
Iba pang pag-aaral sa Tacoma
- Non-Small Cell Lung Cancer20 pag-aaral
- Kanser sa Suso18 pag-aaral
- Ulcerative Colitis15 pag-aaral
- Multiple Myeloma13 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Colorectal Cancer9 pag-aaral
- Metastatic Cancer9 pag-aaral
- Melanoma7 pag-aaral
- Kanser sa Ovary7 pag-aaral
- Kanser sa Tiyan6 pag-aaral
- Kanser sa Esophagus6 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.